Tests that help predict responsiveness to immunotherapy so patients can focus on likely options.
Consented intake · your records travel with you · nothing moves without your sign-off
Oxford Biodynamics offers liquid biopsy testing of blood and other fluids for treatment-guiding biomarkers, with a focus on responsiveness to immunotherapy. Its immune system profiling helps target the immunotherapies with the highest likelihood of response. For patients considering immunotherapy, this information can inform which options to pursue.
Prefer the source? Oxford Biodynamics (responsiveness to immunotherapy)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Oxford Biodynamics (responsiveness to immunotherapy) handles billing.
We don't have confirmed insurance details for Oxford Biodynamics (responsiveness to immunotherapy) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Oxford's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Cancer types served
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.